Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05023317 · ClinicalTrials.gov registry record · Phase 1

Strengths-based Linkage to Alcohol Care (SLAC) for Hazardous Drinkers in Primary Care

A Phase 1 study, sponsored by VA Office of Research and Development.

Completed
Registry status
Phase 1
Development phase
140
Enrollment target

NCT05023317: Completed Phase 1 study, sponsored by VA Office of Research and Development.

NCT05023317 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05023317, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
Phase 1
Development phase
140 participants
Enrollment target

Study Summary

This pilot study will determine the feasibility, acceptability, and efficacy of Strengths-based Linkage to Alcohol Care (SLAC; a behavioral intervention) to link Veterans, identified as hazardous drinkers in VHA primary care, to alcohol care. Participants screening positive in VA primary care for hazardous drinking and posttraumatic stress disorders (PTSD) and/or depression in the past year will be recruited. Participants will be randomly assigned to one of two study conditions - SLAC plus usual care or usual care only. The investigators will determine the feasibility of conducting a larger scale study to evaluate SLAC in primary care and SLAC's acceptability among key stakeholders (e.g., Veterans, primary care providers). Other outcomes will include exploring whether SLAC improves linkage to an alcohol care or help option and/or reduces alcohol use and mental health (PTSD, depression) symptoms.

Interventions

  • BEHAVIORAL Usual care
  • BEHAVIORAL Strengths-based linkage to alcohol care

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2021-01-01
Est. Completion 2025-12-31
Phase Phase 1

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05023317

The ClinicalTrials.gov registry entry for NCT05023317 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.

NCT05023317 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05023317 about?

NCT05023317 is a clinical study titled "Strengths-based Linkage to Alcohol Care (SLAC) for Hazardous Drinkers in Primary Care". This pilot study will determine the feasibility, acceptability, and efficacy of Strengths-based Linkage to Alcohol Care (SLAC; a behavioral intervention) to link Veterans, identified as hazardous drinkers in VHA primary care, to alcohol care. Participants screening positive in VA primary care for ha...

What is the current status of trial NCT05023317?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 140 participants. The study started on 2021-01-01. Estimated completion is 2025-12-31.

What interventions are being tested in trial NCT05023317?

The interventions under investigation include: Usual care (BEHAVIORAL), Strengths-based linkage to alcohol care (BEHAVIORAL).

Who is sponsoring clinical trial NCT05023317?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.